Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes

Insulin degludec (IDeg) is a new basal insulin with an ultra-long and stable glucose-lowering effect. We compared once-daily IDeg and insulin glargine (IGlar), both in combination with metformin ± dipeptidyl peptidase-4 inhibitors, in a 52-week, open-label, treat-to-target trial in patients with typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Wolden, M L, Rana, A, Mathieu, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237540/
https://www.ncbi.nlm.nih.gov/pubmed/24495158
http://dx.doi.org/10.1111/dom.12271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237540/
https://www.ncbi.nlm.nih.gov/pubmed/24495158
http://dx.doi.org/10.1111/dom.12271

Ejemplares similares